デュポンの分析: ROE、ROA、純利益率の内訳
四半期データ
ROEを2つのコンポーネントに分解
Abbott Laboratories、 ROE の分解(四半期データ)
|
|
|
|
|
|
|
ROE |
= |
ROA |
× |
財務レバレッジ比率 |
| 2025/09/30 |
27.43% |
= |
16.60% |
× |
1.65 |
| 2025/06/30 |
27.65% |
= |
16.64% |
× |
1.66 |
| 2025/03/31 |
27.66% |
= |
16.58% |
× |
1.67 |
| 2024/12/31 |
28.12% |
= |
16.46% |
× |
1.71 |
| 2024/09/30 |
14.49% |
= |
7.76% |
× |
1.87 |
| 2024/06/30 |
14.13% |
= |
7.61% |
× |
1.86 |
| 2024/03/31 |
14.51% |
= |
7.77% |
× |
1.87 |
| 2023/12/31 |
14.83% |
= |
7.82% |
× |
1.90 |
| 2023/09/30 |
13.77% |
= |
7.16% |
× |
1.92 |
| 2023/06/30 |
13.88% |
= |
7.04% |
× |
1.97 |
| 2023/03/31 |
15.68% |
= |
7.87% |
× |
1.99 |
| 2022/12/31 |
18.90% |
= |
9.31% |
× |
2.03 |
| 2022/09/30 |
22.11% |
= |
10.84% |
× |
2.04 |
| 2022/06/30 |
23.44% |
= |
11.53% |
× |
2.03 |
| 2022/03/31 |
21.82% |
= |
10.44% |
× |
2.09 |
| 2021/12/31 |
19.75% |
= |
9.40% |
× |
2.10 |
| 2021/09/30 |
21.04% |
= |
9.82% |
× |
2.14 |
| 2021/06/30 |
18.86% |
= |
8.70% |
× |
2.17 |
| 2021/03/31 |
17.06% |
= |
7.86% |
× |
2.17 |
レポートに基づく:
10-Q (報告日: 2025-09-30), 10-Q (報告日: 2025-06-30), 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31).
ROEを3つの要素に分解
Abbott Laboratories、 ROE の分解(四半期データ)
|
|
|
|
|
|
|
|
|
ROE |
= |
純利益率 |
× |
資産回転率 |
× |
財務レバレッジ比率 |
| 2025/09/30 |
27.43% |
= |
31.88% |
× |
0.52 |
× |
1.65 |
| 2025/06/30 |
27.65% |
= |
32.43% |
× |
0.51 |
× |
1.66 |
| 2025/03/31 |
27.66% |
= |
31.89% |
× |
0.52 |
× |
1.67 |
| 2024/12/31 |
28.12% |
= |
31.95% |
× |
0.52 |
× |
1.71 |
| 2024/09/30 |
14.49% |
= |
13.99% |
× |
0.55 |
× |
1.87 |
| 2024/06/30 |
14.13% |
= |
13.65% |
× |
0.56 |
× |
1.86 |
| 2024/03/31 |
14.51% |
= |
13.96% |
× |
0.56 |
× |
1.87 |
| 2023/12/31 |
14.83% |
= |
14.27% |
× |
0.55 |
× |
1.90 |
| 2023/09/30 |
13.77% |
= |
12.92% |
× |
0.55 |
× |
1.92 |
| 2023/06/30 |
13.88% |
= |
12.83% |
× |
0.55 |
× |
1.97 |
| 2023/03/31 |
15.68% |
= |
13.98% |
× |
0.56 |
× |
1.99 |
| 2022/12/31 |
18.90% |
= |
15.88% |
× |
0.59 |
× |
2.03 |
| 2022/09/30 |
22.11% |
= |
17.52% |
× |
0.62 |
× |
2.04 |
| 2022/06/30 |
23.44% |
= |
18.78% |
× |
0.61 |
× |
2.03 |
| 2022/03/31 |
21.82% |
= |
17.35% |
× |
0.60 |
× |
2.09 |
| 2021/12/31 |
19.75% |
= |
16.42% |
× |
0.57 |
× |
2.10 |
| 2021/09/30 |
21.04% |
= |
17.12% |
× |
0.57 |
× |
2.14 |
| 2021/06/30 |
18.86% |
= |
15.85% |
× |
0.55 |
× |
2.17 |
| 2021/03/31 |
17.06% |
= |
15.33% |
× |
0.51 |
× |
2.17 |
レポートに基づく:
10-Q (報告日: 2025-09-30), 10-Q (報告日: 2025-06-30), 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31).
ROEを5つの要素に分解
Abbott Laboratories、 ROE の分解(四半期データ)
|
|
|
|
|
|
|
|
|
|
|
|
|
ROE |
= |
税負担率 |
× |
利息負担率 |
× |
EBITマージン率 |
× |
資産回転率 |
× |
財務レバレッジ比率 |
| 2025/09/30 |
27.43% |
= |
1.72 |
× |
0.94 |
× |
19.72% |
× |
0.52 |
× |
1.65 |
| 2025/06/30 |
27.65% |
= |
1.77 |
× |
0.94 |
× |
19.55% |
× |
0.51 |
× |
1.66 |
| 2025/03/31 |
27.66% |
= |
1.84 |
× |
0.93 |
× |
18.67% |
× |
0.52 |
× |
1.67 |
| 2024/12/31 |
28.12% |
= |
1.91 |
× |
0.93 |
× |
18.05% |
× |
0.52 |
× |
1.71 |
| 2024/09/30 |
14.49% |
= |
0.85 |
× |
0.92 |
× |
17.86% |
× |
0.55 |
× |
1.87 |
| 2024/06/30 |
14.13% |
= |
0.85 |
× |
0.91 |
× |
17.47% |
× |
0.56 |
× |
1.86 |
| 2024/03/31 |
14.51% |
= |
0.86 |
× |
0.91 |
× |
17.76% |
× |
0.56 |
× |
1.87 |
| 2023/12/31 |
14.83% |
= |
0.86 |
× |
0.91 |
× |
18.20% |
× |
0.55 |
× |
1.90 |
| 2023/09/30 |
13.77% |
= |
0.83 |
× |
0.91 |
× |
17.07% |
× |
0.55 |
× |
1.92 |
| 2023/06/30 |
13.88% |
= |
0.82 |
× |
0.91 |
× |
17.11% |
× |
0.55 |
× |
1.97 |
| 2023/03/31 |
15.68% |
= |
0.83 |
× |
0.92 |
× |
18.24% |
× |
0.56 |
× |
1.99 |
| 2022/12/31 |
18.90% |
= |
0.83 |
× |
0.94 |
× |
20.31% |
× |
0.59 |
× |
2.03 |
| 2022/09/30 |
22.11% |
= |
0.85 |
× |
0.95 |
× |
21.87% |
× |
0.62 |
× |
2.04 |
| 2022/06/30 |
23.44% |
= |
0.85 |
× |
0.95 |
× |
23.22% |
× |
0.61 |
× |
2.03 |
| 2022/03/31 |
21.82% |
= |
0.85 |
× |
0.94 |
× |
21.51% |
× |
0.60 |
× |
2.09 |
| 2021/12/31 |
19.75% |
= |
0.86 |
× |
0.94 |
× |
20.30% |
× |
0.57 |
× |
2.10 |
| 2021/09/30 |
21.04% |
= |
0.88 |
× |
0.94 |
× |
20.83% |
× |
0.57 |
× |
2.14 |
| 2021/06/30 |
18.86% |
= |
0.89 |
× |
0.93 |
× |
19.25% |
× |
0.55 |
× |
2.17 |
| 2021/03/31 |
17.06% |
= |
0.90 |
× |
0.92 |
× |
18.54% |
× |
0.51 |
× |
2.17 |
レポートに基づく:
10-Q (報告日: 2025-09-30), 10-Q (報告日: 2025-06-30), 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31).
ROAを2つのコンポーネントに分解
Abbott Laboratories、 ROA の分解(四半期データ)
|
|
|
|
|
|
|
ROA |
= |
純利益率 |
× |
資産回転率 |
| 2025/09/30 |
16.60% |
= |
31.88% |
× |
0.52 |
| 2025/06/30 |
16.64% |
= |
32.43% |
× |
0.51 |
| 2025/03/31 |
16.58% |
= |
31.89% |
× |
0.52 |
| 2024/12/31 |
16.46% |
= |
31.95% |
× |
0.52 |
| 2024/09/30 |
7.76% |
= |
13.99% |
× |
0.55 |
| 2024/06/30 |
7.61% |
= |
13.65% |
× |
0.56 |
| 2024/03/31 |
7.77% |
= |
13.96% |
× |
0.56 |
| 2023/12/31 |
7.82% |
= |
14.27% |
× |
0.55 |
| 2023/09/30 |
7.16% |
= |
12.92% |
× |
0.55 |
| 2023/06/30 |
7.04% |
= |
12.83% |
× |
0.55 |
| 2023/03/31 |
7.87% |
= |
13.98% |
× |
0.56 |
| 2022/12/31 |
9.31% |
= |
15.88% |
× |
0.59 |
| 2022/09/30 |
10.84% |
= |
17.52% |
× |
0.62 |
| 2022/06/30 |
11.53% |
= |
18.78% |
× |
0.61 |
| 2022/03/31 |
10.44% |
= |
17.35% |
× |
0.60 |
| 2021/12/31 |
9.40% |
= |
16.42% |
× |
0.57 |
| 2021/09/30 |
9.82% |
= |
17.12% |
× |
0.57 |
| 2021/06/30 |
8.70% |
= |
15.85% |
× |
0.55 |
| 2021/03/31 |
7.86% |
= |
15.33% |
× |
0.51 |
レポートに基づく:
10-Q (報告日: 2025-09-30), 10-Q (報告日: 2025-06-30), 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31).
ROAを4つの要素に分解
Abbott Laboratories、 ROA の分解(四半期データ)
|
|
|
|
|
|
|
|
|
|
|
ROA |
= |
税負担率 |
× |
利息負担率 |
× |
EBITマージン率 |
× |
資産回転率 |
| 2025/09/30 |
16.60% |
= |
1.72 |
× |
0.94 |
× |
19.72% |
× |
0.52 |
| 2025/06/30 |
16.64% |
= |
1.77 |
× |
0.94 |
× |
19.55% |
× |
0.51 |
| 2025/03/31 |
16.58% |
= |
1.84 |
× |
0.93 |
× |
18.67% |
× |
0.52 |
| 2024/12/31 |
16.46% |
= |
1.91 |
× |
0.93 |
× |
18.05% |
× |
0.52 |
| 2024/09/30 |
7.76% |
= |
0.85 |
× |
0.92 |
× |
17.86% |
× |
0.55 |
| 2024/06/30 |
7.61% |
= |
0.85 |
× |
0.91 |
× |
17.47% |
× |
0.56 |
| 2024/03/31 |
7.77% |
= |
0.86 |
× |
0.91 |
× |
17.76% |
× |
0.56 |
| 2023/12/31 |
7.82% |
= |
0.86 |
× |
0.91 |
× |
18.20% |
× |
0.55 |
| 2023/09/30 |
7.16% |
= |
0.83 |
× |
0.91 |
× |
17.07% |
× |
0.55 |
| 2023/06/30 |
7.04% |
= |
0.82 |
× |
0.91 |
× |
17.11% |
× |
0.55 |
| 2023/03/31 |
7.87% |
= |
0.83 |
× |
0.92 |
× |
18.24% |
× |
0.56 |
| 2022/12/31 |
9.31% |
= |
0.83 |
× |
0.94 |
× |
20.31% |
× |
0.59 |
| 2022/09/30 |
10.84% |
= |
0.85 |
× |
0.95 |
× |
21.87% |
× |
0.62 |
| 2022/06/30 |
11.53% |
= |
0.85 |
× |
0.95 |
× |
23.22% |
× |
0.61 |
| 2022/03/31 |
10.44% |
= |
0.85 |
× |
0.94 |
× |
21.51% |
× |
0.60 |
| 2021/12/31 |
9.40% |
= |
0.86 |
× |
0.94 |
× |
20.30% |
× |
0.57 |
| 2021/09/30 |
9.82% |
= |
0.88 |
× |
0.94 |
× |
20.83% |
× |
0.57 |
| 2021/06/30 |
8.70% |
= |
0.89 |
× |
0.93 |
× |
19.25% |
× |
0.55 |
| 2021/03/31 |
7.86% |
= |
0.90 |
× |
0.92 |
× |
18.54% |
× |
0.51 |
レポートに基づく:
10-Q (報告日: 2025-09-30), 10-Q (報告日: 2025-06-30), 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31).
当期純利益率の分解
Abbott Laboratories、純利益率の分解(四半期データ)
|
|
|
|
|
|
|
|
|
純利益率 |
= |
税負担率 |
× |
利息負担率 |
× |
EBITマージン率 |
| 2025/09/30 |
31.88% |
= |
1.72 |
× |
0.94 |
× |
19.72% |
| 2025/06/30 |
32.43% |
= |
1.77 |
× |
0.94 |
× |
19.55% |
| 2025/03/31 |
31.89% |
= |
1.84 |
× |
0.93 |
× |
18.67% |
| 2024/12/31 |
31.95% |
= |
1.91 |
× |
0.93 |
× |
18.05% |
| 2024/09/30 |
13.99% |
= |
0.85 |
× |
0.92 |
× |
17.86% |
| 2024/06/30 |
13.65% |
= |
0.85 |
× |
0.91 |
× |
17.47% |
| 2024/03/31 |
13.96% |
= |
0.86 |
× |
0.91 |
× |
17.76% |
| 2023/12/31 |
14.27% |
= |
0.86 |
× |
0.91 |
× |
18.20% |
| 2023/09/30 |
12.92% |
= |
0.83 |
× |
0.91 |
× |
17.07% |
| 2023/06/30 |
12.83% |
= |
0.82 |
× |
0.91 |
× |
17.11% |
| 2023/03/31 |
13.98% |
= |
0.83 |
× |
0.92 |
× |
18.24% |
| 2022/12/31 |
15.88% |
= |
0.83 |
× |
0.94 |
× |
20.31% |
| 2022/09/30 |
17.52% |
= |
0.85 |
× |
0.95 |
× |
21.87% |
| 2022/06/30 |
18.78% |
= |
0.85 |
× |
0.95 |
× |
23.22% |
| 2022/03/31 |
17.35% |
= |
0.85 |
× |
0.94 |
× |
21.51% |
| 2021/12/31 |
16.42% |
= |
0.86 |
× |
0.94 |
× |
20.30% |
| 2021/09/30 |
17.12% |
= |
0.88 |
× |
0.94 |
× |
20.83% |
| 2021/06/30 |
15.85% |
= |
0.89 |
× |
0.93 |
× |
19.25% |
| 2021/03/31 |
15.33% |
= |
0.90 |
× |
0.92 |
× |
18.54% |
レポートに基づく:
10-Q (報告日: 2025-09-30), 10-Q (報告日: 2025-06-30), 10-Q (報告日: 2025-03-31), 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31).